Skip to main content Skip to navigation

Steroids

  • Barnes D.
    Use of steroids in the treatment of relapse.
    In: Thompson A, McDonald I.
    Key advances in the efficient management of multiple sclerosis.
    London:Royal Society of Medicine Press;1999.

  • Barnes D, Hughes RAC, Morris RW, et al.
    Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis.
    Lancet 1997;349: 902-906.
    Abstract

  • Burton JM, O'Connor PW, Hohol M, et al.
    Oral versus intravenous steroids for treatment of relapses in multiple sclerosis.
    Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD006921.
    Abstract

  • Chataway J, Porter B, Riazi A, et al.
    Home versus outpatient administration of intravenous steroids for multiple-sclerosis relapses: a randomised controlled trial.
    Lancet Neurology 2006;5:565-571.
    Abstract

  • Craig J, Young CA, Boggild M, et al.
    A randomised controlled trial comparing rehabilitation against standard therapy in multiple sclerosis patients receiving intravenous steroid treatment.
    J Neurol Neurosurg Psychiatry 2003;74(9):1225-1230.
    Abstract

  • Créange A, Debouverie M, Jaillon-Rivière V, et al.
    Home administration of intravenous methylprednisolone for multiple sclerosis relapses: the experience of French multiple sclerosis networks.
    Mult Scler 2009;15(9);1085-1091.
    Abstract

  • Ennis M, Shaw P, Barnes F, et al.
    Developing and auditing multiple sclerosis relapse management guidelines.
    Br J Neurosci Nurs 2008;4(6):266-271.

  • Matheson F, Porter B.
    The evolution of a relapse clinic for multiple sclerosis: Challenges and recommendations.
    Br J Neurosci Nurs 2006; 2(4):180-186.